跳至主要内容
临床试验/ISRCTN78082983
ISRCTN78082983已完成未知

Effect of obstructive sleep apnoea on retinal vasculature reactivity following CPAP withdrawal

niversity of Oxford (UK)0 个研究点目标入组 37 人开始时间: 2014年10月23日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
37

研究概览

简要总结

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35201404/ (added 25/02/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Objectively confirmed obstructive sleep apnoea (at the time of original diagnosis) with an oxygen desaturation index (ODI, >4% dips) or AHI of >20 (this threshold will exclude participants with borderline OSA, in whom there may be little experimental effect)
  • 2. Currently >20/h oxygen desaturations (>4% dips) returning on any night during home nocturnal pulse oximetry performed for a 4-night period without CPAP, prior to entry into the study
  • 3. Treated with CPAP for more than 12 months, minimum compliance 4h per night
  • 4. ODI <10 during treatment (obtained during the preliminary week of oximetry monitoring, from the first 3 nights of oximetry monitoring on CPAP, before the 4 nights CPAP withdrawal)
  • 5. Age between 20 and 75 years at trial entry
  • 6. Written informed consent

排除标准

  • 1. Previous ventilatory failure (awake resting arterial oxygen saturation <93% or arterial PCO2> 6kPa) or severe respiratory disorders other than OSA
  • 2. Unstable, untreated coronary or peripheral artery disease, severe arterial hypertension(>180/110mmHg), severe arterial hypotension (<90/60mmHg)
  • 3. Previously diagnosed with Cheyne-Stokes breathing
  • 4. Current professional driver
  • 5. History of any sleep-related driving accident or other accident
  • 6. Acute inflammatory disease
  • 7. Acute or chronic hepatic or renal disease
  • 8. Known type 1 or 2 diabetes (likely to have low retinal reactivity even on CPAP)
  • 9. Known severe vascular disease (likely to have low retinal reactivity even on CPAP)
  • 10. Mental or physical disability precluding informed consent or compliance with the protocol
  • 11. Non-feasible trial follow-up (for example, distance from follow-up centre, physical inability)
  • 12. Epilepsy: flickering light used for retinal provocation could lead to a seizure
  • 13. Lens opacities: this could lead to insufficient contrast and make it impossible to image the retinal vasculature

研究者

发起方
niversity of Oxford (UK)

相似试验